Permanent, lowered HLA Class I Expression using Lentivirus Vectors with shRNA Constructs: Averting Cytotoxocity by Alloreactive T Lymphocytes
Transplant Proc. 38: 3184-3188
Transplantation of many tissues requires histocompatibility matching of human leukocyte antigens (HLA) to prevent graft rejection, to reduce the level of immunosuppression needed to maintain graft survival, and to minimize the risk of graft-versus-host disease, particularly in the case of bone marrow transplantation. However, recent advances in fields of gene delivery and genetic regulation technologies have opened the possibility of engineering grafts that display reduced levels of HLA expression.
READ ARTICLE
Return